Clinical trial · Interventional
Oncogeriatric Intervention and Follow-up at Home
Oncogeriatric Intervention and Follow-up at Home to Improve Quality of Life and the Possibility to Accomplish Cancer Treatment in Multimorbid Elderly
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is a randomized study of patients living in four municipalities in Eastern Jutland. After geriatric assessment half of the patients will be offered a tailor-made intervention in their homes. The follow-up will last for at least 90 days and include treatment of the patients' multimorbidity, e.g. of dehydration, anaemia, infections, and malnutrition. The other half of the patients, the results of the assessment and recommendations will be given to the patients and their general practitioner. The primary efficacy variables are accomplishment of planned cancer treatment, reduction of complications and admissions to hospital and increased quality of life,. If geriatric assessment and a tailor-made follow-up result in a better quality of life with less complications and admissions the offer may be extended to a longer period, younger age groups and other cancer diagnoses.
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Gastrointestinal Neoplasms | Digestive System Neoplasm | ALIAS | 0.90 |
| Geriatric Assessment | — | UNRESOLVED | — |
| Geriatrics | — | UNRESOLVED | — |
| Head and Neck Neoplasms | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Lung Neoplasms | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Polypharmacy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Geriatric Follow up | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Geriatric follow up
- interventionNames
- Other: Geriatric Follow up
- type
- NO_INTERVENTION
- label
- Control
- description
- Usual care
Primary outcomes (3)
- measure
- Success rate of admittance to initial planned oncological treatment
- timeFrame
- An average of 12 weeks
- description
- Oncological specialist evaluates if treatment is completed as planned or if eventual deviations are of minor or major character
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 70 years or older with cancer of the head and neck, upper gastro intestinal cancer, colo-rectal cancer or Lung cancer, refered to Aarhus University Hospital for evaluation regarding oncological treatment on the Oncology Department at Aarhus University * Living in following municipalities: Odder (excl. of the island of Thunø), Faurskov, Skanderborg og Aarhus * frail or vulnerable by CGA * Signed informed consent. For incapacitated patients: informed consent by relatives Exclusion Criteria: * evaluated 'fit´ by CGA * Referred to specialized palliative care at time of first visit at the Oncology department * Do not wish to participate
References
Publications (1)
- DERIVEDGregersen M, Jensen K, Orum M. The impact of multidisciplinary geriatric follow-up on quality of life in older, non-surgical prefrail and frail patients with cancer A randomized controlled trial. J Geriatr Oncol. 2024 Nov;15(8):102069. doi: 10.1016/j.jgo.2024.102069. Epub 2024 Sep 16. PMID 39288507